Neogenomics (NEO) Non-Current Deferred Tax Liability (2016 - 2026)
Neogenomics filings provide 14 years of Non-Current Deferred Tax Liability readings, the most recent being $17.4 million for Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 16.79% to $17.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $17.4 million, a 16.79% decrease, with the full-year FY2025 number at $18.2 million, down 82.33% from a year prior.
- Non-Current Deferred Tax Liability hit $17.4 million in Q1 2026 for Neogenomics, down from $18.2 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $129.6 million in Q4 2022 to a low of $17.4 million in Q1 2026.
- Median Non-Current Deferred Tax Liability over the past 5 years was $24.3 million (2023), compared with a mean of $38.0 million.
- Biggest five-year swings in Non-Current Deferred Tax Liability: surged 2864.97% in 2022 and later plummeted 82.33% in 2025.
- Neogenomics' Non-Current Deferred Tax Liability stood at $129.6 million in 2022, then crashed by 81.25% to $24.3 million in 2023, then soared by 324.58% to $103.1 million in 2024, then plummeted by 82.33% to $18.2 million in 2025, then dropped by 4.22% to $17.4 million in 2026.
- The last three reported values for Non-Current Deferred Tax Liability were $17.4 million (Q1 2026), $18.2 million (Q4 2025), and $20.8 million (Q3 2025) per Business Quant data.